CD40 ligand level – vascular inflammation activity and long6term prognosis in coronary heart disease patients

CD40 ligand level – vascular inflammation activity and long6term prognosis in coronary heart disease patients

Aim. To study prognostic value of plasma soluble CD40 ligand (sCD40L) level in patients with various coronary heart disease (CHD) forms.Material and methods. In total, 65 CHD patients were examined, including 26 with stable effort angina (SEA), functional class (FC) I6III; 23 – with unstable angina...

Full description

Bibliographic Details
Main Authors:	O. P. Shevchenko, O. F. Prirodova, A. O. Shevchenko, O. V. Orlova, A. N. Britov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2008-02-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	soluble сd40 ligand form coronary heart disease survival adverse cardiovascular events
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1058

Similar Items

Clinical value of soluble CD40 ligand in coronary heart disease patients
by: O. P. Shevchenko, et al.
Published: (1970-01-01)

PROGNOSTIC VALUE OF SOLUBLE CD40 LIGAND AFTER LIVER TRANSPLANTATION IN CHILDREN WITH CONGENITAL AND HEREDITARY DISEASES OF HEPATOBILIARY SYSTEM
by: O. P. Shevchenko, et al.
Published: (2012-05-01)

EFFECT OF CYTOMEGALOVIRUS INFECTION ON THE PREDICTIVE VALUE OF CD-40 LIGAND IN HEART TRANSPLANT RECIPIENTS
by: O. P. Shevchenko, et al.
Published: (2012-09-01)

CD40 ligand in coronary heart disease patients with Type 2 diabetes mellitus
by: O. P. Shevchenko, et al.
Published: (2006-10-01)

Effect of IL-35 on soluble CD40 ligand-induced injury of vascular endothelial cells
by: LI Ming, SUN Hai-ling, LIU Juan-li, GUO Wei-wei
Published: (2022-11-01)

Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease
by: Kotb Abbass Metwalley, et al.
Published: (2020-06-01)

Association Between Soluble CD40 Ligand and Hypercholesterolemia in Children and Adolescents
by: Aynur Küçükçongar Yavaş, et al.
Published: (2017-03-01)

Assessment of serum soluble CD40 ligand levels in patients with chronic rhinosinusitis
by: Zhichen Liu, MD, et al.
Published: (2024-03-01)

Serum CD40 ligand levels and persistent lone atrial fibrillation
by: Timuçin Altın
Published: (2016-07-01)

Role of OX40 and its ligand as costimulatory modulators in cancer immunotherapy
by: Aliya I Sani, et al.
Published: (2021-07-01)

The Proinflammatory Soluble CD40 Ligand Is Associated with the Systemic Extent of Stable Atherosclerosis
by: Tiago Pereira-da-Silva, et al.
Published: (2021-01-01)

Relationship between serum level of CD40 ligand and persistent lone atrial fibrillation
by: Evin Bozçalı, et al.
Published: (2016-07-01)

Soluble CD40 Ligand as a Promising Biomarker in Cancer Diagnosis
by: Alireza Pazoki, et al.
Published: (2024-07-01)

Successful Management of Neutropenia in a Patient with CD40 Ligand Deficiency by Immunoglobulin Replacement Therapy
by: Lida Atarod, et al.
Published: (2007-03-01)

Effect of IL-35 on the adhesion of human umbilical vein endothelial cells after sCD40L stimulation
by: GUO Weiwei, ZHAO Pingping, YU Lulu, LI Ming
Published: (2023-03-01)

COMPARATIVE ANALYSIS OF SOLUBLE OF CD40 LIGAND LEVELS IN HEART RECIPIENTS TREATED WITH CYCLOSPORINE A AND TACROLIMUS
by: O. P. Shevchenko, et al.
Published: (2012-05-01)

Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
by: Charlotte Grosdidier, et al.
Published: (2019-10-01)

Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection
by: T V Popkova, et al.
Published: (2008-05-01)

Preliminary results on the effects of CD40/CD40L interactions and SAC-induction on IFN-gamma expression in human schistosomiasis
by: Silvia ML Montenegro, et al.
Published: (2001-09-01)

OX40 ligand newly expressed on bronchiolar progenitors mediates influenza infection and further exacerbates pneumonia
by: Taizou Hirano, et al.
Published: (2016-03-01)

A synthetic methodology for the preparation of a water-soluble quaternized amino phosphine oxide ligand
by: Ioannis D. Kostas, et al.
Published: (2022-01-01)

Induction of Apoptosis in Cancer Cells of pre-B ALL Patients after Exposure to Platelets, Platelet-Derived Microparticles and Soluble CD40 Ligand
by: Morteza Yaftian, et al.
Published: (2018-01-01)

Expressions of vascular endothelial cadherin and soluble Fas ligand in patients with viral myocarditis and their correlations
by: Hu Hongmei, et al.
Published: (2024-10-01)

Concepts for agonistic targeting of CD40 in immuno-oncology
by: David M. Richards, et al.
Published: (2020-02-01)

Analyses of the soluble levels of sCD40L, sCD62P and sCD40 in pediatric sickle cell anemia patients with abnormal transcranial Doppler
by: Cinthya Pereira Leite Costa de Araújo, et al.
Published: (2024-07-01)

The relation between lead exposure and inflammation / endothelial dysfunction
by: Lutfiye Tutkun, et al.
Published: (2020-06-01)

Relationship between bladder cancer and polymorphisms of OX40 (rs17568) and OX40L (rs1234313) genes in a Turkish population
by: Osman Bilen, et al.
Published: (2023-03-01)

Oncolytic adenovirus encoding decorin and CD40 ligand inhibits tumor growth and liver metastasis via immune activation in murine colorectal tumor model
by: Yejing Rong, et al.
Published: (2024-09-01)

Evaluation of the CD40 receptor-ligand system in the patients with atrial fibrillation of non-valvular genesis
by: O. N. Ogurkova, et al.
Published: (2022-12-01)

Molecular Mingling: Multimodal Predictions of Ligand Promiscuity in Pentameric Ligand-Gated Ion Channels
by: Filip Koniuszewski, et al.
Published: (2022-05-01)

Association of CD40 -1C/T Polymorphism in the 5′-Untranslated Region with Chronic HBV Infection
by: Cheng Zhou, et al.
Published: (2015-01-01)

Pregnancy-associated plasma protein – a new biochemical marker of acute coronary syndrome and poor prognosis predictor in coronary heart disease patients
by: O. P. Shevchenko, et al.
Published: (2006-08-01)

Association of soluble CD40 levels with ‐1 C > T CD40 polymorphism and chronic kidney disease in systemic lupus erythematosus
by: Raziel Tapia‐Llanos, et al.
Published: (2019-12-01)

The effect of temperature and ligand structure on the solubility of gold nanoparticles
by: Mandana Tarakame Samani, et al.
Published: (2021-01-01)

Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure
by: Gianluca Campo, et al.
Published: (2021-05-01)

The synthesis of cis- and trans-3-(4-hydroxyphenyl)cyclobutanecarboxylic acids and the study of their derivatives as GPR-40 receptor ligands
by: I. O. Feskov, et al.
Published: (2020-12-01)

Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy
by: Sadia Zafar, et al.
Published: (2017-02-01)

N<sup>6</sup>-Methyladenosine Directly Regulates CD40L Expression in CD4<sup>+</sup> T Lymphocytes
by: Ellen C. N. van Vroonhoven, et al.
Published: (2023-07-01)

Design of a humanized CD40 agonist antibody with specific properties using AlphaFold2 and development of an anti-PD-L1/CD40 bispecific antibody for cancer immunotherapy
by: Kun Du, et al.
Published: (2025-02-01)

The role of CD40 receptor-ligand system in the development of diabetes mellitus and its complications
by: Irina Arkad'evna Bondar', et al.
Published: (2011-09-01)